doi: 10.1111/bph.15977.
- PMID: 36316276
- DOI: 10.1111/bph.15977
Abstract
Background and purpose: Psychedelics elicit prosocial, antidepressant and anxiolytic effects via neuroplasticity, neurotransmission and neuro-immunomodulatory mechanisms. Whether psychedelics affect the brain endocannabinoid system and its extended version, the endocannabinoidome (eCBome) or the gut microbiome, remains unknown.
Experimental approach: Adult C57BL/6N male mice were administered lysergic acid diethylamide (LSD) or saline for 7 days. Sociability was assessed in the direct social interaction and three chambers tests. Prefrontal cortex and hippocampal endocannabinoids, endocannabinoid-like mediators and metabolites were quantified via high-pressure liquid chromatography with tandem mass spectrometry (HPLC-MS/MS). Neurotransmitter levels were assessed via HPLC-UV/fluorescence. Gut microbiome changes were investigated by 16S ribosomal DNA sequencing.
Key results: LSD increased social preference and novelty and decreased hippocampal levels of the N-acylethanolamines N-linoleoylethanolamine (LEA), anandamide (N-arachidonoylethanolamine) and N-docosahexaenoylethanolamine (DHEA); the monoacylglycerol 1/2-docosahexaenoylglycerol (1/2-DHG); the prostaglandins D2 (PGD2 ) and F2α (PGF2α ); thromboxane 2 and kynurenine. Prefrontal eCBome mediator and metabolite levels were less affected by the treatment. LSD decreased Shannon alpha diversity of the gut microbiota, prevented the decrease in the Firmicutes:Bacteroidetes ratio observed in saline-treated mice and altered the relative abundance of the bacterial taxa Bifidobacterium, Ileibacterium, Dubosiella and Rikenellaceae RC9.
Conclusions and implications: The prosocial effects elicited by repeated LSD administration are accompanied by alterations of hippocampal eCBome and kynurenine levels, and the composition of the gut microbiota. Modulation of the hippocampal eCBome and kynurenine pathway might represent a mechanism by which psychedelic compounds elicit prosocial effects and affect the gut microbiome.
Keywords: 5-hydroxytryptamine system, endocannabinoidome, gut microbiome, kynurenine, lysergic acid diethylamide, repeated, serotonergic system, sociability
© 2022 British Pharmacological Society.
Similar articles
-
Rapid and Concomitant Gut Microbiota and Endocannabinoidome Response to Diet-Induced Obesity in Mice.mSystems. 2019 Dec 17;4(6):e00407-19. doi: 10.1128/mSystems.00407-19.PMID: 31848310 Free PMC article.
-
Alterations of brain endocannabinoidome signaling in germ-free mice.Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Dec;1865(12):158786. doi: 10.1016/j.bbalip.2020.158786. Epub 2020 Aug 11.PMID: 32795503
-
Modulation of DNA methylation and protein expression in the prefrontal cortex by repeated administration of D-lysergic acid diethylamide (LSD): Impact on neurotropic, neurotrophic, and neuroplasticity signaling.Prog Neuropsychopharmacol Biol Psychiatry. 2022 Dec 20;119:110594. doi: 10.1016/j.pnpbp.2022.110594. Epub 2022 Jun 28.PMID: 35777526
-
Germ-free mice exhibit profound gut microbiota-dependent alterations of intestinal endocannabinoidome signaling.J Lipid Res. 2020 Jan;61(1):70-85. doi: 10.1194/jlr.RA119000424. Epub 2019 Nov 5.PMID: 31690638 Free PMC article.
-
Neurobiological Processes Induced by Aerobic Exercise through the Endocannabinoidome.Cells. 2021 Apr 17;10(4):938. doi: 10.3390/cells10040938.PMID: 33920695 Free PMC article. Review.
Cited by
-
Seeking the Psilocybiome: Psychedelics meet the microbiota-gut-brain axis.Int J Clin Health Psychol. 2023 Apr-Jun;23(2):100349. doi: 10.1016/j.ijchp.2022.100349. Epub 2022 Dec 14.PMID: 36605409 Free PMC article.
References
REFERENCES
-
- Alexander, S. P., Christopoulos, A., Davenport, A. P., Kelly, E., Mathie, A., Peters, J. A., Veale, E. L., Armstrong, J. F., Faccenda, E., Harding, S. D., Pawson, A. J., Southan, C., Davies, J. A., Abbracchio, M. P., Alexander, W., Al-hosaini, K., Bäck, M., Barnes, N. M., Bathgate, R., … Ye, R. D. (2021). THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein-coupled receptors. British Journal of Pharmacology, 178(S1), S27-S156. https://doi.org/10.1111/bph.15538
-
- Aran, A., Eylon, M., Harel, M., Polianski, L., Nemirovski, A., Tepper, S., Schnapp, A., Cassuto, H., Wattad, N., & Tam, J. (2019). Lower circulating endocannabinoid levels in children with autism spectrum disorder. Molecular Autism, 10, 2. https://doi.org/10.1186/s13229-019-0256-6
-
- Barnes, N. M., & Sharp, T. (1999). A review of central 5-HT receptors and their function. Neuropharmacology, 38, 1083-1152. https://doi.org/10.1016/S0028-3908(99)00010-6
-
- Bligh, E. G., & Dyer, W. J. (1959). A rapid method of total lipid extraction and purification. Canadian Journal of Biochemistry and Physiology, 37, 911-917. https://doi.org/10.1139/y59-099
-
- Boyd, E., Rothlin, E., Bonner, J., Slater, I., & Hodge, H. (1955). Preliminary studies of the metabolism of lysergic acid diethylamide using radioactive carbon-marked molecules. The Journal of Nervous and Mental Disease, 122, 470-471. https://doi.org/10.1097/00005053-195511000-00009
